[1] 王宁,王立军,任筱郿,等.西安城区儿童哮喘患病特点调查研究[J].陕西医学杂志,2018,47(5):674-677. [2] Davies ER, Denney L, Wandel M, et al. Regulation of ectodomain shedding of ADAM33 in vitro and in vivo[J]. Allergy Clin Immunol,2019,143(6): 2281-2284. [3] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)[C].//第二十次全国儿科中西医结合学术会议论文集. 2016:47-61. [4] Pividori M, Schoettler N, Nicolae DL, et al. Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: Genome-wide and transcriptome-wide studies[J]. Lancet Respir Med, 2019,7(6):509-522. [5] Vishweswaraiah S, Ramachandra NB, Jayaraj BS, et al. Haplotype analysis of ADAM33 polymorphisms in asthma: A pilot study[J]. Indian J Med Res, 2019,150(3): 272-281. [6] Fang L, Wu J, Huang T, et al. TGF-beta1 stimulates epithelial-mesenchymal transition mediated by ADAM33[J]. Exp Ther Med, 2018,15(1):985-992. [7] Davies ER, Kelly JF, Howarth PH, et al. Soluble ADAM33 initiates airway remodeling to promote susceptibility for allergic asthma in early life[J]. JCI Insight, 2016,1(11):87632. [8] Ruan Z, Shi Z, Zhang G,et al. Asthma susceptible genes in children: A meta-analysis[J]. Medicine (Baltimore), 2020,99(45):e23051. [9] Li HF, Yan LP, Wang K, et al. Association between ADAM33 polymorphisms and asthma risk:A systematic review and meta-analysis[J]. Respir Res, 2019,20(1):38. [10] Shalaby SM, Abdul-Maksoud RS, Abdelsalam SM, et al. ADAM33 and ADAM12 genetic polymorphisms and their expression in Egyptian children with asthma[J]. Ann Allergy Asthma Immunol, 2016,116(1):31-36. [11] Thongngarm T, Jameekornrak A, Chaiyaratana N, et al. Effect of gene polymorphisms in ADAM33, TGFβ1, VEGFA, and PLAUR on asthma in Thai population[J]. Asian Pac J Allergy Immunol, 2022,40(1):39-46. [12] Farjadian S, Moghtaderi M, Hoseini-Pouya BA,et al. ADAM33 gene polymorphisms in Southwestern Iranian patients with asthma[J]. Iran J Basic Med Sci, 2018,21(8):813-817. [13] Yilihamu N, Wushouer Q, Arkin K, et al. Association of a disintegrin and metalloprotease 33 gene polymorphisms with asthma[J]. Mol Clin Oncol, 2014,2(6):1076-1080. [14] Ning X, Zhang Y, Wu H, et al. Genetic association of ADAM33 polymorphisms with childhood asthma in Chinese Han population: A case-control study[J]. Medicine (Baltimore), 2019,98(42):17327. [15] Fan JG, Wang ZA, Zhao HX. The ADAM33 S2 polymorphism is associated with susceptibility to pediatric asthma in the Chinese Han population[J]. Genet Test Mol Biomarkers, 2015,19(10):573-578. [16] 吴大威,杨玉双,崔清志,等. 8-异前列腺素、ADAM33基因、超敏C反应蛋白在慢性阻塞性肺疾病患者血清中表达的意义[J]. 国际检验医学杂志, 2018, 39(14):1782-1785. [17] 李闯,刘建萍,石金河,等. 哮喘患者血清IL-17A、IL-18、ADAM33及SIP变化与病情程度的关系[J]. 实验与检验医学, 2020,38(3):489-491,520. [18] 方丽萍,陈敏,张方,等. 解整合素-金属蛋白酶33在不同严重程度哮喘患者血清中的表达水平及其与气道慢性炎症的关系[J]. 医学研究生学报, 2017,30(5):521-524. [19] 刘德义,马胜喜,刘雨婷. 解整合素-金属蛋白酶33、1-磷酸鞘氨醇水平与哮喘患者肺功能的关系及其意义[J]. 中国现代医学杂志, 2019,29(21):100-103. |